NPH insulin did not increase the risk of hypoglycemia (34) (evidence Moderate). In an RCT, 19 adults with CFRD-FH+ were randomly assigned to treatment with NPH or with glargine while continuing pre-meal insulin aspart (at least 3 administration per day). Here, INS is linked to Hypoglycemia.